Oscar Health, Inc.: insider trades · United States · SEC (Form 4)

About Oscar Health, Inc.

Oscar Health, Inc. (NYSE: OSCR) is a U.S.-listed healthcare company headquartered in New York City, United States. Founded in 2012, Oscar was built as a technology-driven health insurer with a clear consumer focus: simplify access to care, improve the member experience, and use software and data to make insurance easier to navigate. For francophone investors, Oscar stands out less as a classic incumbent insurer and more as a digital-first healthcare platform wrapped around regulated insurance products. Oscar’s core business is health insurance, with a particular emphasis on the ACA individual marketplace. The company also serves families, small groups, and, since 2020, Medicare Advantage members. Its product mix is anchored in medical coverage sold to consumers and employers, while its technology stack supports enrollment, customer service, care navigation, and increasingly AI-enabled tools. Oscar also positions its platform as an asset in itself, suggesting a broader ambition to leverage its operating capabilities beyond policy administration. Competitive positioning is central to the investment case. Oscar operates in a large but highly regulated U.S. insurance market where scale, pricing discipline, medical cost management, and compliance matter as much as brand and digital experience. The company competes against major national carriers and more specialized ACA-focused insurers. Its differentiators are a user-friendly digital experience, a member-centric brand, and a technology-led operating model. At the same time, Oscar remains exposed to the typical insurance variables: claims volatility, risk adjustment dynamics, regulatory changes, and the economics of the individual marketplace. Recent developments have been constructive on the commercial side. Oscar said it ended 2025 with a record membership base of roughly 3.4 million and entered 2026 with a sharper focus on profitability and margin expansion. In the first quarter of 2026, the company reported approximately $4.6 billion of revenue and reaffirmed its 2026 guidance. Oscar has also launched new affordable health-plan choices and AI features tied to the 2026 open enrollment cycle, while expanding into multiple U.S. markets including New Jersey, Southern Florida, Mississippi, Charlotte, and Dayton. For investors, this suggests a company that is still growth-oriented, but increasingly focused on disciplined execution and profitability. As a NYSE-listed name in the United States, Oscar combines the attributes of a regulated insurer with the optionality of a health-tech platform.